tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Elixirr Discloses Share Sale by Co-Founder’s Family Member, Ferguson Retains 4.5% Stake

Story Highlights
  • Elixirr is a global challenger consultancy that has grown via acquisitions and a Main Market listing.
  • Co-founder Ian Ferguson’s wife sold 2,998 shares, leaving him with a significant 4.51% stake.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Elixirr Discloses Share Sale by Co-Founder’s Family Member, Ferguson Retains 4.5% Stake

Claim 70% Off TipRanks Premium

Elixirr International Plc ( (GB:ELIX) ) has provided an update.

Elixirr International plc has disclosed that Amanda Ferguson, the wife of co-founder and board adviser Ian Ferguson, sold 2,998 ordinary shares in the company on 8 January 2026 at 834p per share. Following the transaction, Ian Ferguson remains beneficially interested in 2,237,385 shares, representing about 4.51% of Elixirr’s issued share capital, indicating that despite the family’s partial disposal, his stake and alignment with shareholders remain significant.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £866.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Spark’s Take on GB:ELIX Stock

According to Spark, TipRanks’ AI Analyst, GB:ELIX is a Outperform.

Elixirr International Plc’s overall stock score is driven by its strong financial performance and positive corporate events, which highlight its growth trajectory and strategic positioning. However, bearish technical indicators suggest caution in the short term. The valuation is fair, supporting a balanced investment outlook.

To see Spark’s full report on GB:ELIX stock, click here.

More about Elixirr International Plc

Elixirr International plc is an award-winning global consulting firm that positions itself as a “challenger consultancy,” working across a wide range of industries, markets and geographies. Founded in 2009, it focuses on collaborative, outcome-driven advisory work and has expanded both organically and through the acquisition of eight boutique firms to broaden capabilities, enter new regions and win new clients. The company, originally admitted to trading on AIM in 2020, moved up to the Main Market of the London Stock Exchange in July 2025, underlining its growth ambitions and maturing capital markets profile.

Average Trading Volume: 48,716

Technical Sentiment Signal: Buy

Current Market Cap: £401.8M

For detailed information about ELIX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1